Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance
Open accessAbstract
OBJECTIVE: Type 2 diabetes and insulin resistance have been associated with mitochondrial dysfunction, but it is debated whether this is a primary factor in the pathogenesis of the disease. To test the concept that mitochondrial dysfunction is secondary to the development of insulin resistance, we employed the unique model of prolonged fasting in humans. Prolonged fasting is a physiologic condition in which muscular insulin resistance develops in the presence of increased free fatty acid (FFA) levels, increased fat oxidation and low glucose and insulin levels. It is therefore anticipated that skeletal muscle mitochondrial function is maintained to accommodate increased fat oxidation unless factors secondary to insulin resistance exert negative effects on mitochondrial function. RESEARCH DESIGN AND METHODS: While in a respiration chamber, twelve healthy males were subjected to a 60 h fast and a 60 h normal fed condition in a randomized crossover design. Afterward, insulin sensitivity was assessed using a hyperinsulinemic-euglycemic clamp, and mitochondrial function was quantified ex vivo in permeabilized muscle fibers using high-resolution respirometry. RESULTS: Indeed, FFA levels were increased approximately ninefold after 60 h of fasting in healthy male subjects, leading to elevated intramuscular lipid levels and decreased muscular insulin sensitivity. Despite an increase in whole-body fat oxidation, we observed an overall reduction in both coupled state 3 respiration and maximally uncoupled respiration in permeabilized skeletal muscle fibers, which could not be explained by changes in mitochondrial density. CONCLUSIONS: These findings confirm that the insulin-resistant state has secondary negative effects on mitochondrial function. Given the low insulin and glucose levels after prolonged fasting, hyperglycemia and insulin action per se can be excluded as underlying mechanisms, pointing toward elevated plasma FFA and/or intramuscular fat accumulation as possible causes for the observed reduction in mitochondrial capacity.
AI snapshot
Written from the paper’s full text.
TL;DR
In healthy lean men, 60 h of fasting induced insulin resistance together with elevated free fatty acids and intramuscular lipids, and it reduced intrinsic skeletal muscle mitochondrial respiratory capacity without changing mitochondrial density. The authors conclude that mitochondrial dysfunction is a secondary consequence of the insulin-resistant/lipid-exposed state rather than its cause.
Key findings
- After 60 h fasting, plasma FFA rose approximately ninefold (1,981 ± 95 vs. 387 ± 37 μmol/l, P < 0.001), plasma glucose fell to 3.72 ± 0.13 mmol/l, and plasma insulin fell to 7.0 ± 0.74 μU/ml; insulin sensitivity index decreased by ∼45% (P < 0.001), with clamp glucose Rd falling from 38.0 ± 2.8 to 18.8 ± 0.9 μmol/kg/min.
- Intramuscular triacylglycerol area fraction increased ∼2.7-fold overall after fasting (P = 0.001), with a ∼3.5-fold increase in type 1 fibers (P < 0.001) and approximately twofold in type 2 fibers (P = 0.015).
- Mitochondrial density markers were unchanged: mtDNA copy number (P = 0.96), OXPHOS protein levels, and citrate synthase activity (76.2 ± 7.3 vs. 70.2 ± 6.6 μmol/min/g protein, P = 0.41).
- Despite increased whole-body fat oxidation (24-h RER 0.91 ± 0.009 fed vs. 0.77 ± 0.003 fasted, P < 0.001), mitochondrial respiration was reduced: state 3 on lipid substrate was lower (P = 0.03), state 3 with parallel Complex I+II input was ∼20% lower (MOG P = 0.01; MOGS P = 0.02; MGS P = 0.04), and maximal FCCP-uncoupled respiration was ∼23% lower (P = 0.008); state 4o and UCP3 were unchanged.
Methods
- Twelve healthy, lean, male volunteers (age 23.6 ± 1.0 years; BMI 22.6 ± 0.5 kg/m²) completed a randomized crossover trial of 60 h fasting versus 60 h normal feeding, with a 2-week washout, while staying in a respiration chamber.
- After each condition, insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp, and mitochondrial function was measured ex vivo in permeabilized skeletal muscle fibers using high-resolution respirometry with multiple substrate/inhibitor protocols.
- Additional measures included indirect calorimetry, blood FFA/glucose/insulin, intramuscular triacylglycerol staining, mtDNA copy number, citrate synthase activity, and OXPHOS/UCP3 Western blotting; comparisons used paired Student t tests and repeated-measures ANOVA.
Limitations
- The paper states that fasting is not a direct model for type 2 diabetes, that it cannot exclude the possibility that reduced mitochondrial function triggers the observed insulin resistance, and that chronic hyperinsulinemia/hyperglycemia may still negatively affect mitochondrial function in type 2 diabetes patients.
- The paper also notes that the high plasma FFA and IMTG values may reflect complete compliance in the respiration chamber, that species differences complicate comparison with animal high-fat feeding studies, and that it cannot exclude muscle-specific fat oxidation being compensated by other organs or effects on metabolic flexibility.
- Evident from the text: the sample was small (n = 12), limited to healthy lean men without diabetes family history, and the intervention was short-term (60 h), so causal direction and generalizability to women, obesity, or type 2 diabetes are not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 45 cited sources checked · 0 supported · 0 flagged
- Findingown data
After 60 h of fasting, state 3 respiration upon malate + octanoyl-carnitine + glutamate (MOG) is significantly lower than in the fed condition.
“Thus, state 3 respiration upon malate + octanoyl-carnitine + glutamate (MOG) was significantly lower in the fasted state compared with the fed condition (P = 0.01, Fig. 5E).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, plasma free fatty acid levels increase approximately ninefold in healthy male subjects.
“Indeed, FFA levels were increased approximately ninefold after 60 h of fasting in healthy male subjects”
- Also stated in: § Plasma parameters. · plain
“Upon 60 h of fasting, plasma FFA increased dramatically, up to 1,981 ± 95 μmol/l vs. 387 ± 37 in the fed condition (P < 0.001).”
Quote in the paperSubstantial claim - Also stated in: § Plasma parameters. · plain
- Findingown data
The reduction in whole-body insulin sensitivity after 60 h of fasting is mainly accounted for by a reduction in insulin-stimulated glucose disposal.
“The reduction in whole-body insulin sensitivity was mainly accounted for by a reduction in insulin-stimulated glucose disposal (ΔRd, P < 0.001, Table 2).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, citrate synthase activity is similar to the fed condition.
“and CS activity (76.2 ± 7.3 vs. 70.2 ± 6.6 μmol/min/g protein, P = 0.41) were similar in the fed versus the fasted state, respectively, confirming an equal mitochondrial mass in both conditions.”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, state 3 respiration upon malate + glutamate + succinate (MGS) is significantly lower than in the fed condition.
“Similar differences were observed for state 3 respiration upon malate + octanoyl-carnitine + glutamate + succinate (MOGS, P = 0.02, Fig. 5E) and malate + glutamate + succinate (MGS, P = 0.04, Fig. 5E).”
Quote in the paperSubstantial claim
- Findingown data
After 60 h of fasting, mitochondrial UCP3 content does not change.
“Mitochondrial UCP3 did not change upon 60 h of fasting in humans and averaged 2.21 ± 0.38 vs. 2.20 ± 0.41 AU in the fed versus fasted condition (P = 0.96).”
Quote in the paperNot a substantial claim - Findingown data
After 60 h of fasting, state 4o respiration is similar between the fed and fasted conditions.
“Finally, state 4o respiration (reflecting mitochondrial proton leak) was similar between the fed and fasted state (P = 0.48, Fig. 5G).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, plasma insulin levels decrease in healthy male subjects.
“In the fasted condition however, plasma insulin levels were markedly reduced to 7.1 ± 0.6 μU/ml at t = 36 h (P < 0.001) and were maintained at this lower level (7.0 μU/ml ± 0.74) at t = 60 h (P < 0.001).”
Quote in the paperNot a substantial claim - Findingown data
After 60 h of fasting, state 3 respiration upon malate + octanoyl-carnitine + glutamate + succinate (MOGS) is significantly lower than in the fed condition.
“Similar differences were observed for state 3 respiration upon malate + octanoyl-carnitine + glutamate + succinate (MOGS, P = 0.02, Fig. 5E) and malate + glutamate + succinate (MGS, P = 0.04, Fig. 5E).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, the intramuscular triacylglycerol area fraction is approximately 2.7-fold higher than in the fed condition.
“elevated intramuscular lipid levels”
- Also stated in: § Intramuscular triacylglycerols. · plain
“The mean intramuscular IMTG area fraction (Fig. 4), was ∼2.7-fold higher after 60 h of fasting in comparison with the fed condition (P = 0.001).”
Quote in the paperSubstantial claim - Also stated in: § Intramuscular triacylglycerols. · plain
- Findingown data
After 60 h of fasting, state 2 respiration is not different between conditions on any of the substrate combinations studied.
“State 2 respiration (i.e., respiration in the presence of substrate alone) was not different between conditions on any of the substrate combinations studied (Fig. 5B).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, OXPHOS protein levels are similar to the fed condition.
“Also, OXPHOS protein levels (Complex I: 21.2 ± 6.4 vs. 17.7 ± 5.7 arbitrary units, P = 0.50; Complex II: 48.7 ± 14.6 vs. 48.3 ± 16.2 AU, P = 0.97; Complex III: 11.6 ± 1.5 vs. 11.9 ± 1.1 AU, P = 0.88; Complex IV: 92.8 ± 7.0 vs. 93.7 ± 9.1 AU, P = 0.85; Complex V: 4.4 ± 0.7 vs. 4.8 ± 0.9, P = 0.66)”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, ADP-stimulated (state 3) respiration on a lipid substrate (malate + octanoyl-carnitine) is significantly reduced compared with the fed condition.
“However, ADP-stimulated (state 3) respiration on a lipid substrate (malate + octanoyl-carnitine, MO) was significantly reduced upon fasting, as compared with the fed situation (P = 0.03, Fig. 5C).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, insulin sensitivity is reduced by approximately 45% in healthy male subjects.
“decreased muscular insulin sensitivity”
- Also stated in: § Insulin sensitivity. · plain
“Insulin sensitivity index was reduced by ∼45% upon 60 h of fasting, as compared with the fed condition (Fig. 2B, P < 0.001).”
Quote in the paperSubstantial claim - Also stated in: § Insulin sensitivity. · plain
- Findingown data
After 60 h of fasting, maximal FCCP-induced uncoupled respiration is reduced by approximately 23% compared with the fed condition.
“Maximal FCCP-induced uncoupled respiration, reflecting the maximal capacity of the electron transport chain, was also reduced by ∼23% after 60 h of fasting (P = 0.008, Fig. 5F).”
Quote in the paperSubstantial claim - Findingown data
After 60 h of fasting, whole-body 24-h fat oxidation is increased in healthy male subjects.
“Despite an increase in whole-body fat oxidation”
- Also stated in: § Indirect calorimetry. · plain
“Additionally, whole-body 24-h fat oxidation was increased upon prolonged fasting as evidenced by a significant reduction in 24-h respiratory exchange ratio (RER) (0.91 ± 0.009 vs. 0.77 ± 0.003 in fed versus fasted, respectively, P < 0.001).”
Quote in the paperNot a substantial claim - Also stated in: § Indirect calorimetry. · plain
- Findingown data
After 60 h of fasting, mitochondrial DNA copy number is similar to the fed condition.
“Mitochondrial DNA copy number was similar in both the fed and the fasting condition (Fig. 5A, P = 0.96).”
Quote in the paperSubstantial claim - Findingown data
Irrespective of the intervention, FCCP enhanced mitochondrial respiration considerably over state 3 values.
“Irrespective of the intervention, FCCP was able to enhance mitochondrial respiration considerably over state 3 values”
Quote in the paperSubstantial claim - Findingown data
In skeletal muscle mitochondria after prolonged fasting, state 3 respiration was reduced by approximately 20% upon all substrates.
“state 3 respiration was reduced by ∼20% upon all substrates”
Quote in the paperSubstantial claim - Findingnone given
The insulin-resistant state after prolonged fasting was accompanied by hypoinsulinemia and hypoglycemia.
“the insulin-resistant state after prolonged fasting was accompanied by hypoinsulinemia and hypoglycemia.”
Quote in the paperSubstantial claim - Findingown data
UCP3 content was similar between the fed and the fasted condition.
“UCP3 content was similar between the fed and the fasted condition.”
Quote in the paperSubstantial claim - Findingown data
FCCP-induced respiration was reduced by approximately 23% upon prolonged fasting.
“FCCP-induced respiration in itself was reduced by ∼23% upon prolonged fasting (Fig. 5F)”
Quote in the paperSubstantial claim - Findingown data
The reduced mitochondrial capacity was not accounted for by a reduction in mitochondrial density.
“The reduced mitochondrial capacity was not accounted for by a reduction in mitochondrial density.”
Quote in the paperSubstantial claim - Findingown data
The reduction in muscle mitochondrial capacity does not (yet) affect the capability of the body to enhance fat oxidation.
“the reduction in muscle mitochondrial capacity does not (yet) affect the capability of the body to enhance fat oxidation.”
Quote in the paperSubstantial claim - Findingown data
Whole-body fat oxidation increased significantly upon prolonged fasting.
“whole-body fat oxidation increased significantly upon prolonged fasting.”
Quote in the paperSubstantial claim - Findingown data
Prolonged fasting decreased metabolic flexibility (the ability to switch from predominantly fat oxidation to glucose oxidation upon insulin stimulation).
“we also detected a decreased metabolic flexibility (i.e., the ability to switch from predominantly fat oxidation to glucose oxidation upon insulin stimulation) upon prolonged fasting (Fig. 3).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Hyperglycemia and insulin action per se can be excluded as underlying mechanisms for the reduction in mitochondrial capacity after prolonged fasting.
“Given the low insulin and glucose levels after prolonged fasting, hyperglycemia and insulin action per se can be excluded as underlying mechanisms”
Quote in the paperSubstantial claim- Rests on an assumption: Ex vivo high-resolution respirometry in permeabilized skeletal muscle fibers reflects in vivo skeletal muscle mitochondrial functional capacity.
- Rests on an assumption: The prolonged fasting model in healthy males is a valid model for testing whether mitochondrial dysfunction is secondary to insulin resistance in humans.
- Interpretationreasoning
The insulin-resistant state has secondary negative effects on mitochondrial function.
“These findings confirm that the insulin-resistant state has secondary negative effects on mitochondrial function.”
Quote in the paperSubstantial claim- Rests on an assumption: Ex vivo high-resolution respirometry in permeabilized skeletal muscle fibers reflects in vivo skeletal muscle mitochondrial functional capacity.
- Rests on an assumption: The prolonged fasting model in healthy males is a valid model for testing whether mitochondrial dysfunction is secondary to insulin resistance in humans.
- Premisecitation
Acute elevation of plasma FFA by lipid infusion is accompanied by downregulation of PGC1α and other genes involved in mitochondrial metabolism.
“Furthermore, we showed that the acute elevation of plasma FFA by lipid infusion is accompanied by downregulation of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1α (PGC1α) and other genes involved in mitochondrial metabolism (9).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Hoeks, 2006, Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids, Diabetologia source
Not checked in the free run.
- Interpretationown data
The observed reduction in skeletal muscle mitochondrial capacity after 60 h of fasting is not explained by changes in mitochondrial density.
“which could not be explained by changes in mitochondrial density.”
- Also stated in: § DISCUSSION · plain
“which was not explained by changes in mitochondrial density.”
Quote in the paperSubstantial claim- Rests on an assumption: Ex vivo high-resolution respirometry in permeabilized skeletal muscle fibers reflects in vivo skeletal muscle mitochondrial functional capacity.
- Also stated in: § DISCUSSION · plain
- Interpretationown data
Mitochondrial mass is equal in the fed and fasted conditions after 60 h of fasting.
“confirming an equal mitochondrial mass in both conditions.”
Quote in the paperSubstantial claim - Premisereasoning
There is no evidence that reduced mitochondrial function is a primary factor in the pathophysiology of type 2 diabetes.
“Although the existence of mitochondrial abnormalities in patients with type 2 diabetes has been extensively reported during the last decade (1–5), there is no evidence that a reduced mitochondrial function is a primary factor in the pathophysiology of this disease.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [1] Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science source
Not checked in the free run.
- cites [2] Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N Engl J Med source
Not checked in the free run.
- cites [3] Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes source
Not checked in the free run.
- cites [4] Phielix, 2008, Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients, Diabetes source
Not checked in the free run.
- cites [5] Mogensen, 2007, Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes, Diabetes source
Not checked in the free run.
- Premisecitation
Previous findings in isolated mouse and human skeletal muscle mitochondria show a dosage-dependent inhibition of ATP synthesis upon incubation with high but physiologic levels of FFA metabolites.
“previous findings in isolated mouse and human skeletal muscle mitochondria showing a dosage-dependent inhibition of ATP synthesis upon incubation with high but physiologic levels of FFA metabolites (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Abdul-Ghani, 2008, Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- Interpretationown data
The reduction in state 3 respiration upon all substrates reduces the possibility that the decline is caused by substrate-specific alterations such as substrate uptake into the mitochondria.
“which reduces the possibility that the decline is caused by substrate-specific alterations such as substrate uptake into the mitochondria”
Quote in the paperSubstantial claim - Premisecitation
The lack of response in the diabetic patients was accompanied by a reduced expression of PGC-1α, CS, and COX.
“the lack of response in the diabetic patients was accompanied by a reduced expression of PGC-1α, CS, and COX.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Asmann, 2006, Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia, Diabetes source
Not checked in the free run.
- Interpretationown data
A combined reduction of both the capacity of the electron transport chain and oxidative phosphorylation underlies the reduced mitochondrial oxidative capacity upon fasting.
“indicating that a combined reduction of both the capacity of the electron transport chain and oxidative phosphorylation underlies the reduced mitochondrial oxidative capacity upon fasting.”
Quote in the paperSubstantial claim - Interpretationreasoning
It is unlikely that the reduced mitochondrial functional capacity observed here is caused by hyperinsulinemia and/or hyperglycemia associated with reduced insulin action.
“It is therefore unlikely that the reduced mitochondrial functional capacity observed here is caused by hyperinsulinemia and/or hyperglycemia associated with reduced insulin action.”
Quote in the paperSubstantial claim - Premisereasoning
FCCP-induced respiration reflects the maximal capacity of the electron transport chain.
“FCCP-induced respiration reflects the maximal capacity of the electron transport chain.”
Quote in the paperSubstantial claim - Interpretationreasoning
Similar (secondary) effects are involved in causing mitochondrial dysfunction.
“and suggests that similar (secondary) effects are involved in causing mitochondrial dysfunction.”
Quote in the paperSubstantial claim - Premisecitation
In human in vivo studies, negative associations between high fatty acid availability and markers for mitochondrial function have been reported.
“Also in human in vivo studies, negative associations between high fatty acid availability and markers for mitochondrial function have been reported.”
Quote in the paperNot a substantial claim - Interpretationown data
The electron transport chain is not rate-limiting in state 3.
“indicating that the electron transport chain is not rate-limiting in state 3”
Quote in the paperSubstantial claim - Premisecitation
A similar reduction in intrinsic mitochondrial capacity, without differences in mitochondrial content, was recently reported by us in type 2 diabetic patients and first degree relatives when compared with BMI- and age-matched obese control subjects.
“a similar reduction in intrinsic mitochondrial capacity, without differences in mitochondrial content, was recently reported by us in type 2 diabetic patients and first degree relatives when compared with BMI- and age-matched obese control subjects (4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Phielix, 2008, Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients, Diabetes source
Not checked in the free run.
- Interpretationreasoning
Fasting interferes with intrinsic mitochondrial capacity in skeletal muscle.
“this finding indicates that fasting interferes with intrinsic mitochondrial capacity in skeletal muscle.”
Quote in the paperSubstantial claim - Premisecitation
Prolonged fasting-induced insulin resistance is not accompanied by hyperglycemia or hyperinsulinemia.
“Furthermore, prolonged fasting-induced insulin resistance is not accompanied by hyperglycemia or hyperinsulinemia, factors that have been suggested to cause mitochondrial dysfunction in diabetes (7,13).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Asmann, 2006, Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia, Diabetes source
Not checked in the free run.
- cites [13] Rabol, 2009, Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes, J Clin Endocrinol Metab source
Not checked in the free run.
- Interpretationreasoning
The reduction in mitochondrial function upon fasting mimics the situation as observed in the diabetic state.
“Thus, the reduction in mitochondrial function upon fasting mimics the situation as observed in the diabetic state”
Quote in the paperSubstantial claim - Interpretationreasoning
The reduction in insulin action in type 2 diabetes may underlie the observed mitochondrial defects.
“Therefore, the reduction in insulin action in type 2 diabetes may underlie the observed mitochondrial defects.”
Quote in the paperSubstantial claim - Interpretationreasoning
The reduced mitochondrial capacity is secondary to the fatty acid surplus associated with the insulin-resistant state.
“These results indicate that the reduced mitochondrial capacity is secondary to the fatty acid surplus associated with the insulin-resistant state.”
Quote in the paperSubstantial claim - Interpretationreasoning
The elevated plasma FFA and/or intramuscular lipid levels associated with the insulin-resistant state are responsible for the secondary negative effects on mitochondrial function.
“Our findings suggest that the elevated plasma FFA and/or intramuscular lipid levels associated with the insulin-resistant state are responsible for the secondary negative effects on mitochondrial function.”
Quote in the paperSubstantial claim- Rests on an assumption: Prolonged fasting in humans is a valid model of the insulin-resistant state for determining whether mitochondrial dysfunction is a consequence rather than a cause of insulin resistance.
- Interpretationown data
The extrapolation from reduced muscle mitochondrial function to reduced whole-body fat oxidative capacity may not be justified.
“Here we show that this extrapolation may not be justified”
Quote in the paperSubstantial claim
- May combine two claims. 22
- Classified as probably not a substantial claim. 30
May combine two claims.
Findingown dataAfter 60 h of fasting, state 3 respiration upon Complex I substrates malate + glutamate is approximately 22% lower, but this difference is not statistically significant.
“Similarly, state 3 upon the Complex I substrates malate + glutamate (MG) was ∼22% lower after fasting, although this did not reach statistical significance (P = 0.12, Fig. 5D).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAfter 60 h of fasting, plasma glucose levels decrease in healthy male subjects.
“During fasting, however, plasma glucose levels gradually decreased to 3.72 ± 0.13 mmol/l at t = 60 h (P < 0.001).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningmtDNA copy number, CS activity, and OXPHOS protein levels remained unaffected by fasting.
“mtDNA copy number, CS activity, and OXPHOS protein levels remained unaffected by fasting.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe absolute plasma FFA values achieved in this study (~2.0 mol/l) are high.
“the absolute values achieved in this study (∼2.0 mol/l) are high.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationPlasma FFA increased upon prolonged fasting.
“The impressive increase in plasma FFA upon prolonged fasting is in line with previous findings in humans (12,39), although the absolute values achieved in this study (∼2.0 mol/l) are high.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe ~2.7-fold increase in IMTG levels after 60 h of fasting is slightly higher in comparison with previous reports.
“the ∼2.7-fold increase in IMTG levels after 60 h of fasting is slightly higher in comparison with previous reports (12,39).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12] Stannard, 2002, Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [39] Johnson, 2006, Effect of short-term starvation versus high-fat diet on intramyocellular triglyceride accumulation and insulin resistance in physically fit men, Exp Physiol source
Not checked in the free run.
May combine two claims.
Findingown data60 h of fasting in humans lowered insulin-stimulated glucose uptake down to ~50% along with drastically elevated plasma FFA and IMTG levels.
“60 h of fasting in humans lowered insulin-stimulated glucose uptake down to ∼50% along with drastically elevated plasma FFA and IMTG levels.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe reduction in insulin-stimulated glucose uptake observed in the present study confirms previous observations showing that prolonged fasting reduced glucose Rd, which was accounted for by a reduction in both insulin-stimulated glucose oxidation and nonoxidative glucose disposal.
“The reduction in insulin-stimulated glucose uptake observed in the present study confirms previous observations showing that prolonged fasting reduced glucose Rd, which was accounted for by a reduction in both insulin-stimulated glucose oxidation and nonoxidative glucose disposal (40).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Bergman, 2007, Effects of fasting on insulin action and glucose kinetics in lean and obese men and women, Am J Physiol Endocrinol Metab source
Not checked in the free run.
May combine two claims.
Findingown dataThe reduction in insulin-stimulated glucose uptake was accompanied by an overall reduction in intrinsic mitochondrial functional capacity in skeletal muscle, despite a pronounced increase in whole-body fat oxidation.
“This was accompanied by an overall reduction in intrinsic mitochondrial functional capacity in skeletal muscle, despite a pronounced increase in whole-body fat oxidation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationInsulin can stimulate mitochondrial biogenesis and increase ATP synthesis in skeletal muscle.
“it has been shown that insulin can stimulate mitochondrial biogenesis and increases ATP synthesis in skeletal muscle (6,7).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Pagel-Langenickel, 2008, PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle, J Biol Chem source
Not checked in the free run.
- cites [7] Asmann, 2006, Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationShort-term elevation of lipid availability reduces insulin-stimulated increase in ATP synthase flux in skeletal muscle.
“Moreover, it was shown in a comparable study that short-term elevation of lipid availability reduces insulin-stimulated increase in ATP synthase flux in skeletal muscle (10), although this may mainly reflect an effect of muscular insulin resistance on ATP flux.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Brehm, 2006, Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPlasma FFA levels negatively correlate with mitochondrial function measured by magnetic resonance spectroscopy.
“Thus, Szendroedi et al. (8) showed that plasma FFA levels negatively correlated with mitochondrial function measured by magnetic resonance spectroscopy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Szendroedi et al. (8) Szendroedi, 2007, Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes, PLoS Med source
Not checked in the free run.
May combine two claims.
InterpretationreasoningElevated plasma FFA and/or intramuscular fat accumulation are possible causes for the observed reduction in mitochondrial capacity after prolonged fasting.
“pointing toward elevated plasma FFA and/or intramuscular fat accumulation as possible causes for the observed reduction in mitochondrial capacity.”
Quote in the paperSubstantial claim- Rests on an assumption: Ex vivo high-resolution respirometry in permeabilized skeletal muscle fibers reflects in vivo skeletal muscle mitochondrial functional capacity.
- Rests on an assumption: The prolonged fasting model in healthy males is a valid model for testing whether mitochondrial dysfunction is secondary to insulin resistance in humans.
Classified as probably not a substantial claim.
PremisecitationExposing human primary muscle cells to insulin upregulates the expression of PGC-1α.
“it has been reported that exposing human primary muscle cells to insulin upregulates the expression of PGC-1α (27).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Al-Khalili, 2005, Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1, Diabetologia source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningSubjects stayed in a respiration chamber during the entire 60 h to ensure compliance to the dietary regime.
“Subject stayed in a respiration chamber during the entire 60 h to ensure compliance to the dietary regime and to allow the measurement of 24 h substrate oxidation and energy expenditure (16).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSeveral approaches to elevate plasma FFA levels are accompanied by hyperinsulinemia and/or hyperglycemia and insulin resistance, all factors that have also been suggested to interfere with mitochondrial capacity.
“several approaches (high-fat feeding and lipid infusion combined with a hyperinsulinemic-euglycemic clamp) to elevate plasma FFA levels are accompanied by hyperinsulinemia and/or hyperglycemia and insulin resistance, all factors that have also been suggested to interfere with mitochondrial capacity (26,29).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [26] Stump, 2003, Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts, Proc Natl Acad Sci U S A source
Not checked in the free run.
- cites [29] Yu, 2006, Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology, Proc Natl Acad Sci U S A source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFasting has been quite convincingly shown to increase UCP3 protein levels in animal studies.
“fasting has been quite convincingly shown to increase UCP3 protein levels in animal studies (36,37).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] Moreno, 2003, Fasting, lipid metabolism, and triiodothyronine in rat gastrocnemius muscle: interrelated roles of uncoupling protein 3, mitochondrial thioesterase, and coenzyme Q, FASEB J source
Not checked in the free run.
- cites [37] Cadenas, 1999, UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged, FEBS Lett source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe study protocol was approved by the Medical Ethical Committee of Maastricht University Medical Centre and all subjects gave written informed consent.
“The study protocol was reviewed and approved by the Medical Ethical Committee of Maastricht University Medical Centre and all subjects gave their written informed consent before participating in the study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMitochondrial membrane potential was impaired upon short-term lipid infusion in healthy individuals, although several other markers of mitochondrial function remained unaffected.
“mitochondrial membrane potential was impaired upon short-term lipid infusion in healthy individuals, although several other markers of mitochondrial function remained unaffected (32).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Chavez, 2009, Effect of short-term free fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals, J Clin Endocrinol Metab
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHigh-fat feeding for 8 weeks in rats resulted in a twofold increase of PGC-1α protein levels.
“high-fat feeding for 8 weeks in rats resulted in a twofold increase of PGC-1α protein levels (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Hoeks, 2008, Mitochondrial function, content and ROS production in rat skeletal muscle: effect of high-fat feeding, FEBS Lett source
Not checked in the free run.
May combine two claims.
PremisecitationPGC-1α expression and the insulin-stimulated increase in skeletal muscle ATP synthesis were reduced upon lipid infusion.
“PGC-1α expression (9) and the insulin-stimulated increase in skeletal muscle ATP synthesis (10) were reduced upon lipid infusion.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] Hoeks, 2006, Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids, Diabetologia source
Not checked in the free run.
- cites [10] Brehm, 2006, Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe average increase in oxygen consumption upon cytochrome C was less than 10% and similar in both conditions.
“The average increase in oxygen consumption upon cytochrome C was less than 10% (underscoring the viability of the muscle fibers) and similar in both conditions (P = 0.54).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn mice, prolonged consumption of a high-fat diet for 16 weeks reduced mitochondrial function.
“it was shown in mice that prolonged consumption of a high-fat diet for the duration of 16 weeks reduced mitochondrial function (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Bonnard, 2008, Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice, J Clin Invest
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll measurements were performed in duplicate.
“All measurements were performed in duplicate.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAt low doses of insulin (reflecting postabsorptive levels), the skeletal mitochondrial ATP synthesis rate was not different between diabetic patients and controls, indicating that there is no intrinsic muscle mitochondrial defect in type 2 diabetic patients.
“it was demonstrated that at low doses of insulin (reflecting postabsorptive levels) the skeletal mitochondrial ATP synthesis rate was not different between diabetic patients and controls, indicating that there is no intrinsic muscle mitochondrial defect in type 2 diabetic patients (7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Asmann, 2006, Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSevere hyperglycemia inhibited respiration in human skeletal muscle, which was restored upon insulin treatment.
“it was reported that severe hyperglycemia inhibited respiration in human skeletal muscle, which was restored upon insulin treatment (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Rabol, 2009, Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes, J Clin Endocrinol Metab source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe increase in plasma FFA upon prolonged fasting is in line with previous findings in humans.
“The impressive increase in plasma FFA upon prolonged fasting is in line with previous findings in humans (12,39)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12] Stannard, 2002, Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men, Am J Physiol Endocrinol Metab source
Not checked in the free run.
- cites [39] Johnson, 2006, Effect of short-term starvation versus high-fat diet on intramyocellular triglyceride accumulation and insulin resistance in physically fit men, Exp Physiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationAn alternative candidate to explain the observed reduction in mitochondrial capacity upon fasting is prolonged exposure to elevated plasma FFA levels.
“An alternative candidate to explain the observed reduction in mitochondrial capacity upon fasting is prolonged exposure to elevated plasma FFA levels.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHyperglycemia increases mitochondrial ROS production in endothelial cells, as well as in other cell types.
“hyperglycemia has been shown to increase mitochondrial ROS production in endothelial cells (28), as well as in other cell types (29).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [28] Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes source
Not checked in the free run.
- cites [29] Yu, 2006, Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology, Proc Natl Acad Sci U S A source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataOxygen fluxes were adjusted for individual differences in mtDNA copy number, and similar results were obtained without this correction.
“Nonetheless, we adjusted the oxygen fluxes for individual differences in mtDNA copy number. However, similar results were obtained without this correction (see supplemental Fig. 1 in the online appendix available at http://diabetes.diabetesjournals.org).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn healthy individuals, a 7 h insulin infusion increased mitochondrial protein synthesis, cytochrome C oxidase (COX), and citrate synthase (CS) enzyme activities and ATP production.
“in healthy individuals, it was shown that a 7 h insulin infusion increased mitochondrial protein synthesis, cytochrome C oxidase (COX), and citrate synthase (CS) enzyme activities and ATP production (26).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Stump, 2003, Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts, Proc Natl Acad Sci U S A source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenFasting is not a direct model for type 2 diabetes.
“However, it should be noted that fasting is not a direct model for type 2 diabetes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenDifferences in absolute levels of plasma FFA achieved in the different studies may contribute to (part of) the variation.
“differences in absolute levels of plasma FFA achieved in the different studies may contribute to (part of) the variation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe study used a randomized crossover design with a 2-week washout period.
“Subjects participated in two experimental trials: a 60 h fast and a 60 h normal fed condition, in a randomized crossover design with a 2-week washout period.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe available data in the literature underpin the notion that fasting-induced lipid accumulation is responsible for reduced insulin sensitivity upon fasting.
“although the available data in the literature underpin the notion that fasting-induced lipid accumulation is responsible for reduced insulin sensitivity upon fasting”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationUCP3 mRNA levels were elevated after 15 h (~5-fold) and 40 h (~10-fold) of fasting in humans.
“UCP3 mRNA levels were also elevated after 15 h (∼5-fold) and 40 h (∼10-fold) of fasting in humans (38).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Tunstall, 2002, Fasting activates the gene expression of UCP3 independent of genes necessary for lipid transport and oxidation in skeletal muscle, Biochem Biophys Res Commun source
Not checked in the free run.
May combine two claims.
Interpretationown dataBoth a reduction in the activity of the electron transport chain and the oxidative phosphorylation system could underlie the reduced state 3 respiration.
“Therefore, both a reduction in the activity of the electron transport chain and the oxidative phosphorylation system could underlie the reduced state 3 respiration.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRaising plasma FFA by high-fat feeding combined with daily heparin injections for 4 weeks in rats increased skeletal muscle mitochondrial biogenesis and mitochondrial enzymes involved in fat oxidation, the citric acid cycle, and the respiratory chain.
“raising plasma FFA by high-fat feeding combined with daily heparin injections for 4 weeks in rats increased skeletal muscle mitochondrial biogenesis and mitochondrial enzymes involved in fat oxidation, the citric acid cycle, and the respiratory chain (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Garcia-Roves, 2007, Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle, Proc Natl Acad Sci U S A source
Not checked in the free run.
May combine two claims.
PremisecitationHigh (postprandial) levels of insulin increased the mitochondrial ATP production rate in nondiabetic subjects, whereas this increase was absent in type 2 diabetic patients.
“high (postprandial) levels of insulin increased the mitochondrial ATP production rate in nondiabetic subjects, whereas this increase was absent in type 2 diabetic patients (7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Asmann, 2006, Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia, Diabetes source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe decrease in mitochondrial capacity in skeletal muscle is counterintuitive, especially since this decrease was substrate-independent and also apparent upon a lipid substrate.
“Therefore, the decrease in mitochondrial capacity in skeletal muscle is counterintuitive, especially since this decrease was substrate-independent and also apparent upon a lipid substrate.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe high plasma FFA and IMTG levels might be caused by complete compliance to the fasting regimen in the present study since, in contrast to other studies, the subjects stayed in a respiration chamber throughout the whole period.
“The high plasma FFA and IMTG levels might be caused by complete compliance to the fasting regimen in the present study since, in contrast to other studies, the subjects stayed in a respiration chamber throughout the whole period.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationIt has generally been assumed that a reduction in muscle mitochondrial function will result in reductions in whole-body fat oxidative capacity.
“it has generally been assumed that a reduction in muscle mitochondrial function will result in reductions in whole-body fat oxidative capacity (3–5,42,43).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [3] Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes source
Not checked in the free run.
- cites [4] Phielix, 2008, Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients, Diabetes source
Not checked in the free run.
- cites [5] Mogensen, 2007, Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes, Diabetes source
Not checked in the free run.
- cites [42] Ortenblad, 2005, Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect, Biochim Biophys Acta source
Not checked in the free run.
- cites [43] Ritov, 2005, Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes, Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationProlonged fasting reduced glucose Rd, which was accounted for by a reduction in both insulin-stimulated glucose oxidation and nonoxidative glucose disposal.
“previous observations showing that prolonged fasting reduced glucose Rd, which was accounted for by a reduction in both insulin-stimulated glucose oxidation and nonoxidative glucose disposal (40).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Bergman, 2007, Effects of fasting on insulin action and glucose kinetics in lean and obese men and women, Am J Physiol Endocrinol Metab source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNot all studies show the effect of prolonged fasting on metabolic flexibility.
“However, not all studies show this effect (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Soeters, 2008, Muscle adaptation to short-term fasting in healthy lean humans, J Clin Endocrinol Metab source
Not checked in the free run.
The paper relies on this without support.
Ex vivo high-resolution respirometry in permeabilized skeletal muscle fibers reflects in vivo skeletal muscle mitochondrial functional capacity.
“mitochondrial function was quantified ex vivo in permeabilized muscle fibers using high-resolution respirometry.”
The paper relies on this without support.
The prolonged fasting model in healthy males is a valid model for testing whether mitochondrial dysfunction is secondary to insulin resistance in humans.
“To test the concept that mitochondrial dysfunction is secondary to the development of insulin resistance, we employed the unique model of prolonged fasting in humans.”
The paper relies on this without support.
Prolonged fasting in humans is a valid model of the insulin-resistant state for determining whether mitochondrial dysfunction is a consequence rather than a cause of insulin resistance.
“the insulin-resistant state after prolonged fasting”
“However, it should be noted that fasting is not a direct model for type 2 diabetes.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondrial oxidative capacity is decreased in skeletal muscle of obese individuals and is considered a consequence of insulin resistance in humans.
“Mitochondrial oxidative capacity is decreased in skeletal muscle of obese individuals and is considered a consequence of insulin resistance in humans (26).”
From Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction (2011) · cites this paper as [26]
Accumulating fatty acids within myocytes interact with ROS-forming peroxides, which lead to lipotoxic effects on mitochondria.
“In particular, accumulating fatty acids within myoctyes interact with ROS-forming peroxides which in turn lead to lipotoxic effects on mitochondria (26).”
From Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction (2011) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Fasted nonoxidative glucose-disposal change does not match its table values
MinorTable 2 reports fasted basal and clamp nonoxidative glucose disposal of 4.2 and 12.6 μmol/kg/min. Their difference is 8.4, not the reported delta of 8.2.
Reported 8.2 · recomputed 8.4
“| NOGD (μmol/kg/min) | | | | Basal | 1.6 ± 0.5 | 4.2 ± 0.8* | | Clamp | 17.2 ± 2.2 | 12.6 ± 0.8* | | Delta | 15.6 ± 2.4 | 8.2 ± 1.1* |”
Fasted clamp glucose-disposal components do not sum to total disposal
MinorTable 2 gives fasted clamp carbohydrate oxidation as 6.6 and nonoxidative glucose disposal as 12.6 μmol/kg/min. These sum to 19.2, rather than the reported glucose Rd of 18.8; the corresponding fed values sum correctly.
Reported 18.8 · recomputed 19.2
“| Clamp | 38.0 ± 2.8 | 18.8 ± 0.9* |”
Plasma FFA concentration is stated in incompatible units
MinorThe discussion calls the achieved plasma FFA concentration approximately 2.0 mol/l, whereas the results give approximately 1,981 μmol/l. The latter is approximately 2.0 mmol/l, a thousandfold lower than 2.0 mol/l.
“the absolute values achieved in this study (∼2.0 mol/l) are high”
“up to 1,981 ± 95 μmol/l vs. 387 ± 37 in the fed condition”
Cites
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339 · see citing works
Calculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365 · see citing works
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · see citing works
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · see citing works
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · see citing works
Diet, muscle glycogen and physical performance.
Bergström, J., Hermansen, L., Hultman, E., & Saltin, B. (1967) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1967.tb03720.x · Cited by 1,740 · cited 1× · see citing works
“After leaving the respiration chamber on the morning of the third day, a muscle biopsy was taken (18) and a hyperinsulinemic-euglycemic clamp procedure (4) was performed.”
MethodYu, T., Robotham, J. L., & Yoon, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511154103 · Cited by 1,246 · see citing works
Assessment of Insulin Sensitivityin Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,062 · see citing works
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887 · see citing works
Variability of Aerobic Performance in the Laboratory and Its Physiologic Correlates
Kuipers, H., VERSTAPPEN, F. T. J., KEIZER, H. A., Geurten, P., & van Kranenburg, G. (1985) · International Journal of Sports Medicine · doi:10.1055/s-2008-1025839 · Cited by 884 · see citing works
Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819 · see citing works
Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Mogensen, M., Sahlin, K., Fernström, M., Glintborg, D., Vind, B. F., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db06-0981 · Cited by 573 · see citing works
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., & Dela, F. (2007) · Diabetologia · doi:10.1007/s00125-007-0594-3 · Cited by 519 · see citing works
Stump, C. S., Short, K. R., Bigelow, M. L., Schimke, J. M., & Nair, K. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332551100 · Cited by 477 · see citing works
Koopman, R., Schaart, G., & Hesselink, M. K. C. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100297 · Cited by 471 · see citing works
Self-citation[2] Citrate synthase from rat liver
Shepherd, D., & Garland, P. B. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13006-2 · Cited by 434 · see citing works
Phielix, E., Schrauwen-Hinderling, V. B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J., Kooi, M. E., Moonen-Kornips, E., Sels, J.-P., Hesselink, M. K. C., et al. (2008) · Diabetes · doi:10.2337/db08-0391 · Cited by 359 · see citing works
Self-citationA dual-respiration chamber system with automated calibration
Schoffelen, P. F. M., Westerterp, K. R., Saris, W. H. M., & ten Hoor, F. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.2064 · Cited by 252 · see citing works
Garcia-Roves, P., Huss, J. M., Han, D.-H., Hancock, C. R., Iglesias-Gutierrez, E., Chen, M., & Holloszy, J. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704024104 · Cited by 246 · see citing works
Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243 · see citing works
Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
Brehm, A., Krssak, M., Schmid, A. I., Nowotny, P., Waldhäusl, W., & Roden, M. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1286 · Cited by 239 · see citing works
UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged
Cadenas, S., Buckingham, J. A., Samec, S., Seydoux, J., Din, N., Dulloo, A. G., & Brand, M. D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01540-9 · Cited by 227 · see citing works
Asmann, Y. W., Stump, C. S., Short, K. R., Coenen-Schimke, J. M., Guo, Z., Bigelow, M. L., & Nair, K. S. (2006) · Diabetes · doi:10.2337/db05-1230 · Cited by 207 · see citing works
Changes in fat oxidation in response to a high-fat diet
Schrauwen, P., van Marken Lichtenbelt, W., Saris, W., & Westerterp, K. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.2.276 · Cited by 168 · see citing works
Self-citationAbdul-Ghani, M. A., Muller, F. L., Liu, Y., Chavez, A. O., Balas, B., Zuo, P., Chang, Z., Tripathy, D., Jani, R., Molina-Carrion, M., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90287.2008 · Cited by 140 · see citing works
Pagel-Langenickel, I., Bao, J., Joseph, J. J., Schwartz, D. R., Mantell, B. S., Xu, X., Raghavachari, N., & Sack, M. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800842200 · Cited by 124 · see citing works
Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men
Stannard, S. R., Thompson, M. W., Fairbairn, K., Huard, B., Sachinwalla, T., & Thompson, C. H. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00108.2002 · Cited by 108 · see citing works
Ørtenblad, N., Mogensen, M., Petersen, I., Højlund, K., Levin, K., Sahlin, K., Beck-Nielsen, H., & Gaster, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.001 · Cited by 101 · see citing works
Schrauwen, P., Joris Hoeks, J., & Hesselink, M. K. C. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.001 · Cited by 97 · see citing works
Self-citationEffects of fasting on insulin action and glucose kinetics in lean and obese men and women
Bergman, B. C., Cornier, M.-A., Horton, T. J., & Bessesen, D. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00613.2006 · Cited by 87 · see citing works
Joris Hoeks, J., van Baak, M. A., Hesselink, M. K. C., Hul, G. B. J., Vidal, H., Saris, W. H. M., & Schrauwen, P. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00175.2003 · Cited by 84 · see citing works
Self-citationAl-Khalili, L., Forsgren, M., Kannisto, K., Zierath, J. R., Lönnqvist, F., & Krook, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1741-3 · Cited by 78 · see citing works
Hoeks, J., Hesselink, M. K. C., Russell, A. P., Mensink, M., Saris, W. H. M., Mensink, R. P., & Schrauwen, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0369-2 · Cited by 74 · see citing works
Self-citationSchrauwen, P., Mensink, M., Schaart, G., Moonen‐Kornips, E., Sels, J.-P. J. E., Blaak, E. E., Russell, A. P., & Hesselink, M. K. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1572 · Cited by 70 · see citing works
Self-citationJohnson, N. A., Stannard, S. R., Rowlands, D. S., Chapman, P. G., Thompson, C. H., O'Connor, H., Sachinwalla, T., & Thompson, M. W. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033399 · Cited by 69 · see citing works
Intramyocellular triacylglycerol in prolonged cycling with high- and low-carbohydrate availability
Johnson, N., Stannard, Mehalski, K., Trenell, M. I., Sachinwalla, T., Thompson, C., & Thompson, M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00833.2002 · Cited by 67 · see citing works
Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
Rabøl, R., Højberg, P. M. V., Almdal, T., Boushel, R., Haugaard, S. B., Madsbad, S., & Dela, F. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1475 · Cited by 66 · see citing works
Hoeks, J., Briedé, J. J., de Vogel, J., Schaart, G., Nabben, M., Moonen-Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.013 · Cited by 63 · see citing works
Self-citationChavez, A. O., Kamath, S., Jani, R., Sharma, L. K., Monroy, A., Abdul-Ghani, M. A., Centonze, V. E., Sathyanarayana, P., Coletta, D. K., Jenkinson, C. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1387 · Cited by 52 · see citing works
Roorda, B. D., Hesselink, M. K. C., Schaart, G., Moonen‐Kornips, E., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., Mensink, R. P., & Schrauwen, P. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400416-jlr200 · Cited by 45 · see citing works
Self-citationTunstall, R. J., Mehan, K. A., Hargreaves, M., Spriet, L. L., & Cameron-Smith, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00473-4 · Cited by 42 · see citing works
Moreno, M., Lombardi, A., De Lange, P., Silvestri, E., Ragni, M., Lanni, A., & Goglia, F. (2003) · The FASEB Journal · doi:10.1096/fj.02-0839fje · Cited by 42 · see citing works
Muscle adaptation to short-term fasting in healthy lean humans
Soeters, M. R., Sauerwein, H. P., Dubbelhuis, P. F., Groener, J. E., Ackermans, M. T., Fliers, E., Aerts, J. M., & Serlie, M. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0250 · Cited by 40 · cited 1× · see citing works
“However, not all studies show this effect (41).”
Background
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · see citing works
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320 · see citing works
Self-citationMetabolic Flexibility in Health and Disease
Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995 · see citing works
Cold acclimation recruits human brown fat and increases nonshivering thermogenesis
van der Lans, A. A. J. J., Joris Hoeks, J., Brans, B. T., Vijgen, G. H. E. J., Visser, M. G. W., Vosselman, M. J., Hansen, J., Jörgensen, J. A., Wu, J., Mottaghy, F. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68993 · Cited by 841 · see citing works
Self-citationShort-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus
Hanssen, M. J. W., Joris Hoeks, J., Brans, B. T., van der Lans, A. A. J. J., Schaart, G., van den Driessche, J. J., Jörgensen, J. A., Boekschoten, M. V., Hesselink, M. K. C., Havekes, B., et al. (2015) · Nature Medicine · doi:10.1038/nm.3891 · Cited by 587 · see citing works
Self-citationShort-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans
Hanssen, M. J. W., van der Lans, A. A. J. J., Brans, B. T., Joris Hoeks, J., Jardon, K. M. C., Schaart, G., Mottaghy, F. M., Schrauwen, P., & Lichtenbelt, W. D. V. M. (2015) · Diabetes · doi:10.2337/db15-1372 · Cited by 293 · see citing works
Self-citationSkeletal muscle insulin resistance: role of mitochondria and other ROS sources
Di Meo, S., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0598 · Cited by 282 · see citing works
HOCKING, S. L., Samocha‐Bonet, D., Milner, K., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 281 · see citing works
Intermittent Fasting: Is the Wait Worth the Weight?
Stockman, M.-C., Thomas, D. D., Burke, J., & Apovian, C. M. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0308-9 · Cited by 235 · see citing works
Lepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232 · see citing works
Demonstration of a day-night rhythm in human skeletal muscle oxidative capacity
van Moorsel, D., Hansen, J., Havekes, B., Scheer, F. A. J. L., Jörgensen, J. A., Hoeks, J., Schrauwen-Hinderling, V. B., Duez, H., Lefebvre, P., Schaper, N. C., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.012 · Cited by 218 · see citing works
Self-citationel Azzouzi, H., Leptidis, S., Dirkx, E., Joris Hoeks, J., van Bree, B., Brand, K., McClellan, E. A., Poels, E. M., Sluimer, J. C., van den Hoogenhof, M. M. G., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.009 · Cited by 203 · see citing works
Self-citationFatty acid metabolism, energy expenditure and insulin resistance in muscle.
Turner, N., Cooney, G., Kraegen, E., & Bruce, C. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0397 · Cited by 203 · see citing works
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
Geisler, C. E., & Renquist, B. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0513 · Cited by 191 · see citing works
Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation
Soeters, M. R., Soeters, P. B., Schooneman, M. G., Houten, S. M., & Romijn, J. A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00397.2012 · Cited by 177 · see citing works
Remie, C. M., Roumans, K. H., Moonen, M. P., Connell, N. J., Havekes, B., Mevenkamp, J., Lindeboom, L., de Wit, V. H., van de Weijer, T., Aarts, S. A., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa072 · Cited by 160 · see citing works
Self-citationFatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise
Catoire, M., Alex, S., Paraskevopulos, N., Mattijssen, F., Evers-van Gogh, I., Schaart, G., Jeppesen, J., Kneppers, A., Mensink, M., Voshol, P. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400889111 · Cited by 150 · see citing works
Self-citationExcess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle
TUMOVA, J., ANDEL, M., & TRNKA, J. (2016) · Physiological Research · doi:10.33549/physiolres.932993 · Cited by 143 · see citing works
Hutchison, A. T., Liu, B., Wood, R. E., Vincent, A. D., Thompson, C. H., O’Callaghan, N. J., Wittert, G., & Heilbronn, L. K. (2018) · Obesity · doi:10.1002/oby.22345 · Cited by 148 · see citing works
van de Weijer, T., Phielix, E., Bilet, L., Williams, E. G., Ropelle, E. R., Bierwagen, A., Livingstone, R., Nowotny, P., Sparks, L. M., Paglialunga, S., et al. (2015) · Diabetes · doi:10.2337/db14-0667 · Cited by 139 · see citing works
Self-citationNew insights into insulin resistance in the diabetic heart
Gray, S., & Kim, J. K. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.001 · Cited by 143 · see citing works
Abbatecola, A. M., Paolisso, G., Fattoretti, P., Evans, W. J., Fiore, V., Dicioccio, L., & Lattanzio, F. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0366-0 · Cited by 137 · see citing works
Espinoza‐Derout, J., Hasan, K. M., Shao, X. M., Jordan, M. C., Sims, C., Lee, D. L., Sinha, S. K., Simmons, Z., Mtume, N., Liu, Y., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00738.2018 · Cited by 108 · see citing works
Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis
Grant, R. W., & Stephens, J. M. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00053.2015 · Cited by 105 · see citing works
Healthy aging and muscle function are positively associated with NAD+ abundance in humans
Janssens, G. E., Grevendonk, L., Perez, R. Z., Schomakers, B. V., de Vogel-van den Bosch, J., Geurts, J. M. W., van Weeghel, M., Schrauwen, P., Houtkooper, R. H., & Hoeks, J. (2022) · Nature Aging · doi:10.1038/s43587-022-00174-3 · Cited by 103 · see citing works
Self-citationHigh Oxidative Capacity Due to Chronic Exercise Training Attenuates Lipid-Induced Insulin Resistance
Phielix, E., Meex, R., Ouwens, D. M., Sparks, L., Hoeks, J., Schaart, G., Moonen-Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2012) · Diabetes · doi:10.2337/db11-1832 · Cited by 99 · see citing works
“whole muscle protein levels in whole muscle by Western blotting (30).”
BackgroundSelf-citationESTERLINE, R. L., Vaag, A. A., Oscarsson, J., & Vora, J. P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0832 · Cited by 97 · see citing works
Fasting as a Therapy in Neurological Disease
Phillips, M. C. L. (2019) · Nutrients · doi:10.3390/nu11102501 · Cited by 96 · see citing works
Muscle mitochondria and insulin resistance: a human perspective
Hoeks, J., & Schrauwen, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.007 · Cited by 94 · see citing works
Self-citationPPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism
van Diepen, J. A., Jansen, P. A. M., Ballak, D. B., Hijmans, A., Hooiveld, G. J. E. J., Rommelaere, S., Galland, F., Naquet, P., Rutjes, F. P. J. T., Mensink, R. P., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.013 · Cited by 92 · see citing works
Self-citationErythropoietin, a Novel Versatile Player Regulating Energy Metabolism beyond the Erythroid System
Wang, L., Di, L., & Noguchi, C. T. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9518 · Cited by 91 · see citing works
Putti, R., Migliaccio, V., Sica, R., & Lionetti, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00426 · Cited by 90 · see citing works
Santamarina, A. B., Carvalho‐Silva, M., Gomes, L. M., Okuda, M. H., de Santana, A. A., STRECK, E. L., Seelaender, M. C. L., do Nascimento, C. M. O., Ribeiro, E. B., Lira, F. S., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.07.002 · Cited by 88 · see citing works
Electronic Cigarette Use and the Risk of Cardiovascular Diseases
Espinoza-Derout, J., Shao, X. M., Lao, C. J., Hasan, K. M., Rivera, J. C., Jordan, M. C., Echeverria, V., Roos, K. P., Sinha-Hikim, A. P., & Friedman, T. C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.879726 · Cited by 96 · see citing works
Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance
Hanssen, M. J. W., Wierts, R., Joris Hoeks, J., Gemmink, A., Brans, B. T., Mottaghy, F. M., Schrauwen, P., & Lichtenbelt, W. D. V. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3465-8 · Cited by 86 · see citing works
Self-citationDaniele, G., Eldor, R., Merovci, A., Clarke, G. D., Xiong, J., Tripathy, D., Taranova, A. G., Abdul-Ghani, M. A., & DeFronzo, R. A. (2013) · Diabetes · doi:10.2337/db13-1130 · Cited by 83 · see citing works
Dynamic changes of muscle insulin sensitivity after metabolic surgery
Gancheva, S., Ouni, M., Jeleník, T., Koliaki, C. C., Szendroedi, J., Toledo, F. G. S., Markgraf, D. F., Pesta, D. H., Mastrototaro, L., Filippo, E. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12081-0 · Cited by 78 · see citing works
Juraschek, S. P., Shantha, G. P. S., Chu, A. Y., Miller, E. R., Güallar, E., Hoogeveen, R. C., Ballantyne, C. M., Brancati, F. L., Schmidt, M. I., Pankow, J. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055113 · Cited by 77 · see citing works
Clark, I. A., Atwood, C., Bowen, R. L., Paz-Filho, G., & Vissel, B. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005850 · Cited by 75 · see citing works
Vendelbo, M. H., Clasen, B. F., Treebak, J. T., Møller, L. L. V., Krusenstjerna-Hafstrøm, T., Madsen, M. A., Nielsen, T. S., Stødkilde‐Jørgensen, H., Pedersen, S. B., Jørgensen, J. O. L., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00207.2011 · Cited by 75 · see citing works
Most, J., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.231 · Cited by 75 · see citing works
Bravard, A., Bonnard, C., Durand, A., Chauvin, M., Favier, R. J. M., Vidal, H., & Rieusset, J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00455.2010 · Cited by 72 · see citing works
Martinez, B., & Ortiz, R. M. (2017) · Physiology · doi:10.1152/physiol.00018.2016 · Cited by 71 · see citing works
Quintens, R., Singh, S., Lemaire, K., Bock, K. D., Granvik, M., Schraenen, A., Vroegrijk, I. O. C. M., Costa, V., Noten, P. V., Lambrechts, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056719 · Cited by 69 · see citing works
Rieusset, J. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.006 · Cited by 68 · see citing works
Antoni, R., Johnston, K. L., Collins, A. L., & Robertson, M. D. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114515005346 · Cited by 68 · see citing works
Intramyocellular lipid droplets and insulin sensitivity, the human perspective
Gemmink, A., Goodpaster, B. H., Schrauwen, P., & Hesselink, M. K. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.010 · Cited by 62 · see citing works
Self-citationJuraschek, S. P., Selvin, E., Miller, E. R., Brancati, F. L., & Young, J. H. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.09.005 · Cited by 57 · see citing works
Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
Martin, S. D., Morrison, S., Konstantopoulos, N., & McGee, S. L. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.001 · Cited by 54 · see citing works
Gemmink, A., Bosma, M., Kuijpers, H., Hoeks, J., Schaart, G., van Zandvoort, M., Schrauwen, P., & Hesselink, M. (2016) · Diabetologia · doi:10.1007/s00125-016-3865-z · Cited by 54 · see citing works
Self-citationSkeletal muscle in healthy humans exhibits a day-night rhythm in lipid metabolism
Held, N. M., Wefers, J., van Weeghel, M., Daemen, S., Hansen, J., Vaz, F. M., van Moorsel, D., Hesselink, M. K. C., Houtkooper, R. H., & Schrauwen, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100989 · Cited by 53 · see citing works
Self-citationWefers, J., Connell, N. J., Fealy, C. E., Andriessen, C., de Wit‐Verheggen, V. H. W., van Moorsel, D., Moonen‐Kornips, E., Jörgensen, J. A., Hesselink, M. K. C., Havekes, B., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101050 · Cited by 51 · see citing works
Self-citationden Kamp, Y. J. M. O., Gemmink, A., de Ligt, M., Dautzenberg, B., Moonen‐Kornips, E., Jörgensen, J. A., Schaart, G., ESTERLINE, R. L., Pava, D., Joris Hoeks, J., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101620 · Cited by 46 · see citing works
Self-citationPátková, J., Anděl, M., & Trnka, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358709 · Cited by 44 · see citing works
Halle, J. L., Pena, G. S., Paez, H., Castro, A. J., Rossiter, H., Visavadiya, N. P., Whitehurst, M., & Khamoui, A. V. (2019) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00028.2019 · Cited by 44 · see citing works
Jana, B. A., Chintamaneni, P. K., Krishnamurthy, P. T., Wadhwani, A., & Mohankumar, S. K. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4551-7 · Cited by 44 · see citing works
Prolonged fasting-induced metabolic signatures in human skeletal muscle of lean and obese men
Bak, A. M., Vendelbo, M. H., Christensen, B., Viggers, R., Bibby, B. M., Rungby, J., Jørgensen, J. O. L., Møller, N., & Jessen, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200817 · Cited by 43 · see citing works
Jørgensen, S. W., Hjort, L., Gillberg, L., Justesen, L., Madsbad, S., Brøns, C., & Vaag, A. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2020 · Cited by 42 · see citing works
Wang, L., Jia, Y., Rogers, H. M., Suzuki, N., Gassmann, M., Wang, Q., McPherron, A. C., Kopp, J. B., Yamamoto, M. P., & Noguchi, C. T. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.03.007 · Cited by 42 · see citing works
Kanuri, B., Kanshana, J. S., Rebello, S. C., Pathak, P., Gupta, A. P., Gayen, J. R., Jagavelu, K., & Dikshit, M. (2017) · Scientific Reports · doi:10.1038/srep41009 · Cited by 40 · see citing works
Factors regulating fat oxidation in human skeletal muscle
Kiens, B., Alsted, T. J., & Jeppesen, J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00898.x · Cited by 40 · see citing works
Preoperative Fasting among Adult Patients for Elective Surgery in a Kenyan Referral Hospital
Njoroge, G., Kivuti-Bitok, L., & Kimani, S. T. (2017) · International Scholarly Research Notices · doi:10.1155/2017/2159606 · Cited by 40 · see citing works
de Goede, P., Foppen, E., Ritsema, W. I. G. R., Korpel, N. L., Yi, C., & Kalsbeek, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00554 · Cited by 41 · see citing works
Liu, B., Hutchison, A. T., Thompson, C. H., Lange, K., Wittert, G. A., & Heilbronn, L. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa707 · Cited by 39 · see citing works
Joris Hoeks, J., de Wilde, J., Hulshof, M. F. M., van den Berg, S. A. A., Schaart, G., van Dijk, K. W., Smit, E., & Mariman, E. C. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027274 · Cited by 39 · see citing works
Increased Oxygen Consumption in Human Adipose Tissue From the “Brown Adipose Tissue” Region
Vijgen, G. H. E. J., Sparks, L. M., Bouvy, N. D., Schaart, G., Joris Hoeks, J., Lichtenbelt, W. D. V. M., & Schrauwen, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1348 · Cited by 38 · see citing works
Self-citationHouser, D. S., Crocker, D. E., Tift, M. S., & Champagne, C. D. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00101.2012 · Cited by 37 · see citing works
Connor, T., Martin, S. D., Howlett, K. F., & McGee, S. L. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12315 · Cited by 37 · see citing works
Joris Hoeks, J., Mensink, M., Hesselink, M. K. C., Ekroos, K., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1884 · Cited by 37 · see citing works
Self-citationThe effect of diet and exercise on lipid droplet dynamics in human muscle tissue
Daemen, S., van Polanen, N., & Hesselink, M. K. C. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.167015 · Cited by 36 · see citing works
Self-citationSparks, L. M., Gemmink, A., Phielix, E., Bosma, M., Schaart, G., Moonen-Kornips, E., Jörgensen, J. A., Nascimento, E. B. M., Hesselink, M. K. C., Schrauwen, P., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3885-8 · Cited by 34 · see citing works
Self-citationFatty Acid Transporter CD36 Mediates Hypothalamic Effect of Fatty Acids on Food Intake in Rats
Moullé, V. S. F., Foll, C. L., Philippe, E., Kassis, N., Rouch, C., Marsollier, N., Bui, L. C., Guissard, C., Dairou, J., Lorsignol, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074021 · Cited by 34 · see citing works
Connell, N., Grevendonk, L., Fealy, C., Moonen-Kornips, E., Bruls, Y., Schrauwen-Hinderling, V., de Vogel, J., Hageman, R., Geurts, J., Zapata-Perez, R., et al. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxab193 · Cited by 33 · see citing works
Self-citationClaycombe, K., Roemmich, J. N., Johnson, L. K., Vomhof‐DeKrey, E. E., & Johnson, W. T. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.003 · Cited by 33 · see citing works
AWAD, S. S., & Lobo, D. N. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834f0078 · Cited by 33 · see citing works
Acute exercise reverses starvation-mediated insulin resistance in humans
Frank, P., Katz, A., Andersson, E. A., & Sahlin, K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2012 · Cited by 33 · see citing works
Anthocyanins ameliorate obesity-associated metainflammation: Preclinical and clinical evidence
Santamarina, A. B., Calder, P. C., Estadella, D., & Pisani, L. P. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.04.004 · Cited by 37 · see citing works
Targeting thermogenesis and related pathways in anti-obesity drug discovery
Clapham, J. C., & Arch, J. R. S. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.004 · Cited by 29 · see citing works
Remie, C. M. E., Janssens, G. E., Bilet, L., van Weeghel, M., Duvivier, B. M. F. M., de Wit‐Verheggen, V. H. W., Connell, N. J., Jörgensen, J. A., Schomakers, B. V., Schrauwen‐Hinderling, V. B., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05558-5 · Cited by 30 · see citing works
Self-citationfor the GDS group, Apostolopoulou, M., Straßburger, K., Herder, C., Knebel, B., Kotzka, J., Szendroedi, J., & Roden, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4038-9 · Cited by 28 · see citing works
Transdermal insulin delivery with microwave and fatty acids as permeation enhancers
Harjoh, N., Wong, T. W., & Caramella, C. M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119416 · Cited by 28 · see citing works
Lim, E. L., Hollingsworth, K. G., Smith, F. E., Thelwall, P. E., & Taylor, R. (2011) · Clinical Science · doi:10.1042/cs20100611 · Cited by 28 · see citing works
Targeting the Metabolic Paradigms in Cancer and Diabetes
Bosso, M., Haddad, D., Madhoun, A. S. A., & Al‐Mulla, F. (2024) · Biomedicines · doi:10.3390/biomedicines12010211 · Cited by 26 · see citing works
Krautbauer, S., Eisinger, K., Neumeier, M., Hader, Y., Buettner, R., Schmid, P. M., Aslanidis, C., & Buechler, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086866 · Cited by 26 · see citing works
Dahlmans, D., Houzelle, A., Andreux, P. A., Wang, X., Jörgensen, J. A., Moullan, N., Daemen, S., Kersten, S., Auwerx, J. H., & Joris Hoeks, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27401 · Cited by 26 · see citing works
Harmsen, J., Kotte, M., Habets, I., Bosschee, F., Frenken, K. G., Jörgensen, J. A., de Kam, S. S., Moonen‐Kornips, E., Cissen, J., Doligkeit, D., et al. (2023) · The Journal of Physiology · doi:10.1113/jp285523 · Cited by 25 · see citing works
Self-citationClarke, S. D., Lee, K., Andrews, Z. B., Bischof, R. J., Fahri, F., Evans, R. G., Clarke, I. J., & Henry, B. A. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00036.2012 · Cited by 25 · see citing works
Lund, M. T., Larsen, S., Hansen, M. V., Courraud, J., Floyd, A. K., Støckel, M., Helge, J. W., & Dela, F. (2018) · Acta Physiologica · doi:10.1111/apha.13032 · Cited by 23 · see citing works
Andriessen, C., Doligkeit, D., Moonen‐Kornips, E., Mensink, M., Hesselink, M. K. C., Joris Hoeks, J., & Schrauwen, P. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.10.010 · Cited by 23 · see citing works
Self-citationJørgensen, W., Jelnes, P., Rud, K. A., Hansen, L. L., Grunnet, N., & Quistorff, B. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00103.2012 · Cited by 23 · see citing works
Cardinale, D. A., Gejl, K. D., Petersen, K. G., Nielsen, J., Ørtenblad, N., & Larsen, F. J. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00829.2020 · Cited by 21 · see citing works
van Herpen, N. A., Sell, H., Eckel, J., Schrauwen, P., & Mensink, R. P. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1330015 · Cited by 22 · see citing works
Self-citationBoon, M. R., Hanssen, M. J. W., Brans, B. T., Hülsman, C. J. M., Joris Hoeks, J., Nahon, K. J., Bakker, C., van Klinken, J. B., Havekes, B., Schaart, G., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4752-6 · Cited by 22 · see citing works
Mongraw‐Chaffin, M., Matsushita, K., Brancati, F. L., Astor, B. C., Coresh, J., Crawford, S., Schmidt, M. I., Hoogeveen, R. C., Ballantyne, C. M., & Young, J. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051237 · Cited by 20 · see citing works
Santamarina, A. B., Mennitti, L. V., de Souza, E. A., Mesquita, L. M. D. S., Noronha, I. H., Vasconcelos, J. R., Prado, C. M., & Pisani, L. P. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.09.024 · Cited by 19 · see citing works
Storoschuk, K. L., Lesiuk, D., Nuttall, J., LeBouedec, M. A., Khansari, A., Islam, H., & Gurd, B. J. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155768 · Cited by 20 · see citing works
Lipid-induced insulin resistance does not impair insulin access to skeletal muscle
Kolka, C. M., Richey, J. M., Castro, A. V., Broussard, J. L., Ionut, V., & Bergman, R. N. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2015 · Cited by 19 · see citing works
Borer, K. T., Lin, P., & Wuorinen, E. C. (2021) · Nutrients · doi:10.3390/nu13124342 · Cited by 18 · see citing works
Bittel, A. J., Bittel, D. C., Mittendorfer, B., Patterson, B. W., Okunade, A. L., Abumrad, N. A., Reeds, D. N., & Cade, W. T. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002538 · Cited by 18 · see citing works
van Beek, S. M. M., Bruls, Y. M. H., Vanweert, F., Fealy, C. E., Connell, N. J., Schaart, G., Moonen‐Kornips, E., Jörgensen, J. A., Vaz, F. M., Smeets, E. T. H. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35798-5 · Cited by 16 · see citing works
Self-citation
- Authors
- Hoeks, J., van Herpen, N. A., Mensink, M., Moonen-Kornips, E., van Beurden, D., Hesselink, M. K. C., & Schrauwen, P.
- Affiliations
- School for Nutrition, Toxicology and Metabolism, Department of Human Biology, Maastricht University Medical Centre, Maastricht, the Netherlands;
- Wageningen University & Research (NL)
- Maastricht University Medical Centre (NL)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-06-23
- Volume
- 59
- Issue
- 9
- Pages
- 2117-2125
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2927932
- OpenAlex
- W2134172979
- Semantic Scholar
- 44db7ec23aadf67e5033f75f26c8e2276e3c7411
- Cited by
- 156
- References
- 44
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 15 · 2022: 5 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 11 · 2017: 10 · 2016: 10 · 2015: 7 · 2014: 15 · 2013: 19 · 2012: 15
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (acceptedVersion, cc-by-nc-nd)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (918.96.618, 917.66.359)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- prolonged fasting, insulin resistance, free fatty acids, fat oxidation, type 2 diabetes pathogenesis, mitochondrial respiration, hyperinsulinemic-euglycemic clamp, high-resolution respirometry, skinned muscle fibers
- MeSH terms
- Adult, Body Weight, Citrate (si)-Synthase, Diabetes Mellitus, Type 2, DNA, Mitochondrial, Fasting, Fatty Acids, Nonesterified, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Lipids, Male, Mitochondria, Reference Values, Triglycerides, Glucose Clamp Technique, Muscle, Skeletal, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review